5351 - 5360 of 6466 Results
Title
Year
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 29
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 11
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 23
-
OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 15
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 11
-
OPENTitle: Heterogeneous pain trajectories in persons with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 102Issue #:Start Page: 42End Page: 50Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.07.006Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.07.006Citation Count: 10
-
OPENTitle: Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 32End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.027Citation Count: 9
-
OPENTitle: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 7End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdfCitation Count: 6
-
OPENTitle: Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 16End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.010Best OA location URL: http://www.prd-journal.com/article/S1353802020308609/pdfCitation Count: 61
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 7